Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Metabolic Reprogramming of T Cells by Dual UCP2 and IL-17 Blockade Enhances Immunity Against Pancreatic Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 14, 2025
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease.
Journal: The New England journal of medicine
Published: September 18, 2024
Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 02, 2022
Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia.
Journal: The Journal of clinical investigation
Published: February 22, 2022
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.
Journal: Transplantation and cellular therapy
Published: June 01, 2021
Hedgehog blockade in steroid-refractory sclerotic chronic graft-versus-host disease.
Journal: British journal of haematology
Published: May 02, 2021
PTCy and "The Story of the Three Bears".
Journal: Bone marrow transplantation
Published: October 15, 2020
Mechanism of action of posttransplantation cyclophosphamide: more than meets the eye.
Journal: The Journal of clinical investigation
Published: May 08, 2019
Last Updated: 09/26/2026